XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net Income (Loss) Attributable to Parent $ 311 $ 418
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used for) operating activities:    
Depreciation, amortization and accretion 439 431
Amortization of deferred financing costs and other non-cash interest 8 7
Stock-based compensation expense, net 38 41
Asset write-down charges 6 0
Deferred income tax (benefit) provision 4 1
Other non-cash adjustments, net 4 2
Changes in assets and liabilities, excluding the effects of acquisitions:    
Increase (decrease) in accrued interest (59) (51)
Increase (decrease) in accounts payable (19) (5)
Increase (decrease) in other liabilities (160) (127)
Decrease (increase) in receivables 101 28
Decrease (increase) in other assets (74) (139)
Net cash provided by (used for) operating activities 599 606
Cash flows from investing activities:    
Capital expenditures (320) (341)
Payments for acquisitions, net of cash acquired (1) (67)
Other investing activities, net 1 1
Net cash provided by (used for) investing activities (320) (407)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 0 999
Principal payments on debt and other long-term obligations (14) (19)
Borrowings under revolving credit facility 0 1,434
Payments under revolving credit facility (670) (1,305)
Net issuances (repayments) under commercial paper program 1,138 (524)
Payments for financing costs 0 (10)
Purchases of common stock (27) (28)
Dividends/distributions paid on common stock (688) (686)
Net cash provided by (used for) financing activities (261) (139)
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents 18 60
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (1) 1
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period 281 327
Cash, cash equivalents and restricted cash and cash equivalents at end of period $ 298 $ 388